NO20006191D0 - Vaksine - Google Patents

Vaksine

Info

Publication number
NO20006191D0
NO20006191D0 NO20006191A NO20006191A NO20006191D0 NO 20006191 D0 NO20006191 D0 NO 20006191D0 NO 20006191 A NO20006191 A NO 20006191A NO 20006191 A NO20006191 A NO 20006191A NO 20006191 D0 NO20006191 D0 NO 20006191D0
Authority
NO
Norway
Prior art keywords
vaccine
Prior art date
Application number
NO20006191A
Other languages
English (en)
Other versions
NO20006191L (no
Inventor
Lauren O Bakaletz
Joseph Cohen
Guy Dequesne
Yves Lobet
Original Assignee
Smithkline Beecham Biolog
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog, Univ Ohio State Res Found filed Critical Smithkline Beecham Biolog
Publication of NO20006191D0 publication Critical patent/NO20006191D0/no
Publication of NO20006191L publication Critical patent/NO20006191L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
NO20006191A 1998-06-11 2000-12-06 Vaksine NO20006191L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812613.9A GB9812613D0 (en) 1998-06-11 1998-06-11 Vaccine
PCT/US1999/011980 WO1999064067A2 (en) 1998-06-11 1999-05-28 Vaccine

Publications (2)

Publication Number Publication Date
NO20006191D0 true NO20006191D0 (no) 2000-12-06
NO20006191L NO20006191L (no) 2001-02-07

Family

ID=10833591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006191A NO20006191L (no) 1998-06-11 2000-12-06 Vaksine

Country Status (16)

Country Link
US (2) US20060257418A1 (no)
EP (1) EP1083926A4 (no)
JP (1) JP2002517218A (no)
KR (1) KR20010052767A (no)
CN (1) CN1201818C (no)
AU (1) AU761293B2 (no)
BR (1) BR9910973A (no)
CA (1) CA2330238A1 (no)
GB (1) GB9812613D0 (no)
HU (1) HUP0302965A2 (no)
IL (2) IL140094A0 (no)
NO (1) NO20006191L (no)
NZ (1) NZ508616A (no)
PL (1) PL362988A1 (no)
WO (1) WO1999064067A2 (no)
ZA (1) ZA200007255B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
HUP0200664A2 (en) 1999-03-19 2002-06-29 Smithkline Beecham Biolog Streptococcus vaccine
GB0003502D0 (en) * 2000-02-15 2000-04-05 Smithkline Beecham Sa Vaccine
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0025493D0 (en) * 2000-10-17 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0102470D0 (en) * 2001-01-31 2001-03-14 Smithkline Beecham Biolog Novel compounds
KR100639397B1 (ko) * 2004-03-18 2006-10-26 (주)에스제이바이오메드 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물
DE602006018308D1 (de) 2005-07-08 2010-12-30 Nationwide Childrens Hospital Chimärer impfstoff für haemophilus influenzae-induzierte infektion
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2633772C (en) 2005-12-22 2015-09-15 Ralph Leon Biemans Pneumococcal polysaccharide conjugate vaccine
ES2809167T3 (es) 2006-01-17 2021-03-03 Forsgren Arne Una novedosa proteína de Haemophilus influenzae expuesta en la superficie (proteína E; pE)
PL2167121T3 (pl) 2007-06-26 2016-01-29 Glaxosmithkline Biologicals Sa Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae
JP5442641B2 (ja) * 2009-01-07 2014-03-12 大塚製薬株式会社 全インフルエンザ菌の測定方法
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
AU2014225330B2 (en) 2013-03-08 2018-11-01 Lauren O. Bakaletz Transcutaneous dosage formulation
CN103405760A (zh) * 2013-06-19 2013-11-27 中国科学院海洋研究所 迟缓爱德华氏菌菌毛蛋白FimA的应用
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
CA3063954A1 (en) 2017-05-30 2018-12-06 Glaxosmithline Biologicals S.A. Methods for manufacturing an adjuvant
CA3083078A1 (en) 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin purification
BR112021000965A2 (pt) 2018-08-07 2021-04-27 Glaxosmithkline Biologicals S.A. processos e vacinas
US20220339282A1 (en) 2018-11-29 2022-10-27 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
BR112021024363A2 (pt) 2019-06-05 2022-03-22 Glaxosmithkline Biologicals Sa Purificação de saponina
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
EP1300156A3 (en) * 1993-05-18 2003-05-07 The Ohio State University Research Foundation Otitis media vaccine
US6248562B1 (en) * 1993-11-01 2001-06-19 Research Foundation State University Of New York Chimeric proteins comprising borrelia polypeptides and uses therefor
US5770213A (en) * 1994-05-05 1998-06-23 American Cyanamid Company Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection
US5843464A (en) * 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
GB0003502D0 (en) * 2000-02-15 2000-04-05 Smithkline Beecham Sa Vaccine
DE602006018308D1 (de) * 2005-07-08 2010-12-30 Nationwide Childrens Hospital Chimärer impfstoff für haemophilus influenzae-induzierte infektion

Also Published As

Publication number Publication date
ZA200007255B (en) 2002-02-07
NO20006191L (no) 2001-02-07
US20060257418A1 (en) 2006-11-16
WO1999064067A9 (en) 2002-08-15
CA2330238A1 (en) 1999-12-16
KR20010052767A (ko) 2001-06-25
IL140094A (en) 2006-08-20
NZ508616A (en) 2003-09-26
WO1999064067A2 (en) 1999-12-16
CN1306437A (zh) 2001-08-01
HUP0302965A2 (hu) 2003-12-29
AU4102199A (en) 1999-12-30
BR9910973A (pt) 2001-09-18
GB9812613D0 (en) 1998-08-12
EP1083926A4 (en) 2006-01-18
CN1201818C (zh) 2005-05-18
US20090191234A1 (en) 2009-07-30
EP1083926A1 (en) 2001-03-21
AU761293B2 (en) 2003-05-29
IL140094A0 (en) 2002-02-10
PL362988A1 (en) 2004-11-15
JP2002517218A (ja) 2002-06-18

Similar Documents

Publication Publication Date Title
NO20006191D0 (no) Vaksine
NO20003302L (no) Vaksine
NO20014322D0 (no) Vaksine
NO20004758D0 (no) Vaksinesammensetning
DE69938817D1 (de) Erstellungsverfahren
ATE341990T1 (de) Sigmidoskop
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20020763D0 (no) Vaksine
ATE262513T1 (de) Benzoylpyridazine
IS5694A (is) Bóluefni
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
DE59808995D1 (de) Endomikroskopsystem
DE19842103B4 (de) Stanznietzuführung
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DK0988995T3 (da) Chartek
NO306363B1 (no) Klammer
DK1105498T3 (da) HIV vaccine
ATA126298A (de) Verpuffungsklappe
DE29819079U1 (de) Kombuchalyophilisat
DE59900975D1 (de) Falzwalzenlagerung
DE29802605U1 (de) Etagère
DE29820409U1 (de) Jätharke
DE29809642U1 (de) Mürbehammer
DE29819078U1 (de) Glucuron Präparat